These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 11829890

  • 21. Bacillus Calmette-Guérin therapy in stage Ta/T1 bladder cancer: prognostic factors for time to recurrence and progression.
    Andius P, Holmäng S.
    BJU Int; 2004 May; 93(7):980-4. PubMed ID: 15142147
    [Abstract] [Full Text] [Related]

  • 22. [Prophylactic effect of UFT on the recurrence of bladder cancer].
    Naito K, Hisazumi H, Saka A, Nakamura T, Kanda S, Mikawa I, Ejiri S, Miyagi T, Katsumi T, Kitagawa K.
    Hinyokika Kiyo; 1990 Apr; 36(4):487-94. PubMed ID: 2116083
    [Abstract] [Full Text] [Related]

  • 23. [Periodic prophylactic bladder instillation (PPI) of mitomycin C].
    Mishina T, Watanabe H, Fujiwara T, Kobayashi T, Maegawa M, Nakao M, Nakagawa S.
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):365-71. PubMed ID: 6820896
    [Abstract] [Full Text] [Related]

  • 24. Twelve-year follow up of a randomized prospective trial comparing bacillus Calmette-Guerin and epirubicin as adjuvant therapy in superficial bladder cancer.
    Cheng CW, Chan SF, Chan LW, Chan CK, Ng CF, Cheung HY, Chan SY, Wong WS, Lai FM, To KF, Li ML.
    Int J Urol; 2005 May; 12(5):449-55. PubMed ID: 15948743
    [Abstract] [Full Text] [Related]

  • 25. Combined thermo-chemotherapy for recurrent bladder cancer after bacillus Calmette-Guerin.
    Nativ O, Witjes JA, Hendricksen K, Cohen M, Kedar D, Sidi A, Colombo R, Leibovitch I.
    J Urol; 2009 Oct; 182(4):1313-7. PubMed ID: 19683278
    [Abstract] [Full Text] [Related]

  • 26. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
    Jancke G, Damm O, Rosell J, Jahnson S.
    Scand J Urol Nephrol; 2008 Oct; 42(5):417-21. PubMed ID: 18609266
    [Abstract] [Full Text] [Related]

  • 27. [Preventive value of intravesical thiotepa on the recurrence of Ta-T1 vesical tumors treated by conservative surgery. Apropos of 247 cases a mean follow-up of 88 months].
    Gilloz A, Sauvage I, Gremillet E, Héritier P, Richard A, el Hajj E, Diez-Yanguas J.
    J Urol (Paris); 1987 Oct; 93(4):197-202. PubMed ID: 3119728
    [Abstract] [Full Text] [Related]

  • 28. Management of superficial bladder carcinoma with BCG. Long term follow-up.
    Martínez-Piñeiro JA.
    Prog Clin Biol Res; 1984 Oct; 162B():335-45. PubMed ID: 6438642
    [No Abstract] [Full Text] [Related]

  • 29. Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer.
    Lerner SP, Tangen CM, Sucharew H, Wood D, Crawford ED.
    J Urol; 2007 May; 177(5):1727-31. PubMed ID: 17437798
    [Abstract] [Full Text] [Related]

  • 30. [Results of a prospective study of chemoprophylaxis with alternating mitomycin-C and BCG: complete response and recurrence and progression index].
    Nohales Taurines G, Cortadellas Angel R, Arango Toro O, Bielsa Gali O, Gelabert Mas A.
    Arch Esp Urol; 1996 Sep; 49(7):689-92. PubMed ID: 9020005
    [Abstract] [Full Text] [Related]

  • 31. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy.
    Herr HW.
    J Urol; 2005 Dec; 174(6):2134-7. PubMed ID: 16280743
    [Abstract] [Full Text] [Related]

  • 32. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
    Yumura Y, Oogo Y, Takase K, Hamano A, Yamashita Y, Noguchi S, Satomi Y.
    Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
    [Abstract] [Full Text] [Related]

  • 33. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
    Librenjak D, Situm M, Eterovic D, Dogas Z, Gotovac J.
    Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510
    [Abstract] [Full Text] [Related]

  • 34. [Effect of prophylactic intravesical instillation of BCG for superficial bladder cancer].
    Segawa N, Inamoto T, Nomi H, Ibuki N, Azuma H, Katsuoka Y.
    Hinyokika Kiyo; 2009 Apr; 55(4):175-80. PubMed ID: 19462820
    [Abstract] [Full Text] [Related]

  • 35. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E, Fujimoto H, Mizutani Y, Okajima E, Koga H, Hinotsu S, Shinohara N, Oya M, Miki T, Cancer Registration Committee of the Japanese Urological Association.
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [Abstract] [Full Text] [Related]

  • 36. Intravesical chemotherapy.
    Prout GR.
    Prog Clin Biol Res; 1984 Mar; 162B():125-50. PubMed ID: 6438639
    [No Abstract] [Full Text] [Related]

  • 37. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J, Crego M, Sabaté S, Salvador J, Palou J, Villavicencio H.
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [Abstract] [Full Text] [Related]

  • 38. Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer.
    Ito M, Habuchi T, Watanabe J, Higashi S, Nishiyama H, Wang L, Tsuchiya N, Kamoto T, Ogawa O.
    Urology; 2004 Jul; 64(1):74-8. PubMed ID: 15245939
    [Abstract] [Full Text] [Related]

  • 39. Single instillation of mitomycin C reduces 1st year recurrence following transurethral resection of non-muscle invasive bladder cancer.
    Ather MH, Aziz S, Sulaiman MN.
    J Ayub Med Coll Abbottabad; 2007 Jul; 19(4):18-20. PubMed ID: 18693589
    [Abstract] [Full Text] [Related]

  • 40. [Intravesial instillation of recombination interferon-alpha and pirarubicin in the prophylaxis of local recurrence after resection of the superficial bladder cancer].
    Deng JH, Bai JL, Zhang SS, Ma PC, Wan JH.
    Ai Zheng; 2004 Jul; 23(7):839-41. PubMed ID: 15248924
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.